A study published in the Journal of Nuclear Medicine suggests that a PET radiotracer commonly used for diagnosing Alzheimer's disease can also be used to measure vascular brain changes during PET/MRI scans. The researchers found that combining early-frame F-18 florbetaben PET scans with phase-contrast MRI scans allowed for accurate quantification of cerebral blood flow (CBF). This approach can provide a more comprehensive picture of brain pathology involved in cognitive decline and reduce the cost and inconvenience to patients and their caregivers. The study also suggests that this combined approach can be particularly useful in patients with beta-amyloid deposits who may be cognitively normal.
Tue, 12 Dec 2023 16:00:30 GMT | AuntMinnie